Timing and durability of response to erenumab in patients with episodic migraine - McAllister, Peter J.; Turner, Ira; Reuter, Uwe; Wang, Andrea; Scanlon, James; Klatt, Jan; Chou, Denise E.; Paiva da Silva Lima, Gabriel (Headache, 2021)
Keywords: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized - therapeutic use; Calcitonin Gene-Related Peptide Receptor Antagonists - therapeutic use; calcitonin gene‐related peptide receptor; Cognition; Double-Blind Method; Durability; efficacy; Female; Headache; headache frequency; Humans; Male; Middle Aged; Migraine; Migraine Disorders - drug therapy; Monoclonal antibodies; monoclonal antibody; pain; Patients; Prevention; Reduction; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult; calcitonin gene-related peptide receptor; pain; headache; headache frequency; monoclonal antibody; efficacy